Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable Cancer

MacDonald N : Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care.J. Support. Oncol.5, 157–162 (2007).

10.1038/nature01322

10.1038/nri1415

10.1007/s10555-007-9100-0

10.1056/NEJM199904293401723

10.1126/science.7878464

10.1016/S0149-2918(05)80001-3

10.1016/0959-8049(94)90417-0

10.1200/JCO.2005.06.866

10.1017/S0029665108007131

10.1002/bjs.1800810727

10.1002/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9

10.1080/01635589809514687

10.1207/S15327914NC352_5

10.1207/S15327914NC352_2

10.1038/sj.bjc.6690077

10.1093/ajcn/83.4.735

10.1093/ajcn/83.6.1345

10.1097/00000421-200006000-00011

10.1385/IR:30:3:261

10.1038/sj.bjc.6602419

10.1097/SLA.0b013e3181a3e738

10.1016/j.cell.2006.01.007

10.1038/sj.bjc.6690223

10.1097/MCO.0b013e32832a7902

10.1002/jso.20329

10.1016/j.amjsurg.2007.12.057

10.1038/sj.bjc.6601242

10.1038/sj.bjc.6601789

Wilop S , CrysandtM, BendelM, MahnkenAH, OsiekaR, JostE: Correlation of C-reactive protein with survival and radiographic response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer.Onkologie31(12), 665–670 (2008).

10.1097/JTO.0b013e31819578c8

10.1002/jso.2930360302

Hara M , MatsuzakiY, ShimuzuTet al.: Preoperative serum C-reactive protein level in non-small cell lung cancer.Anticancer Res.27(4), 3001–3004 (2007).

10.1510/icvts.2007.174391

Kasprzyk M , DyszkiewiczW, ZwaruńD, LeśniewskaK, WiktorowiczK: The assessment of acute phase proteins as prognostic factors in patients surgically treated for non-small cell lung cancer.Pneumonol. Alergol. Pol.76(5), 321–326 (2008).

10.1016/j.jtcvs.2008.05.046

10.1016/j.lungcan.2008.04.011

10.1016/j.ejcts.2007.06.017

10.1016/S0748-7983(96)92398-7

10.1097/00000658-199807000-00010

Heys SD , WalkerLG, DeehanDJ, EreminOE: Serum albumin: a prognostic indicator in patients with colorectal cancer.J. R. Coll. Surg. Edinb.43(3), 163–168 (1998).

10.1016/S0002-9610(98)00204-9

10.1007/BF02237249

10.1007/BF02725342

10.1046/j.1365-2168.2001.01669.x

10.1002/bjs.4038

10.1097/00042737-200304000-00006

10.1023/B:DDAS.0000034556.48527.6e

10.1177/147323000503300211

10.3748/wjg.v11.i11.1639

Cengiz O , KocerB, SürmeliS, SantickyMJ, SoranA: Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma?Med. Sci. Monit.12(6), 240–247 (2006).

10.1097/SLA.0b013e3181454171

McMillan DC CrozierJE CannaK AngersonWJ McArdleCS: Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer.Int. J. Colorectal Dis. (8) 881–886 (2007).

10.1038/sj.bjc.6604027

10.1038/sj.bjc.6602305

10.1002/jso.21154

10.1038/sj.bjc.6604926

Roxburgh CSD WallaceAM GuthrieGK HorganPG McMillanDC: The relationship between patient and tumour related factors the systemic inflammatory response and cancer specific survival in patients under going potentially curative surgery for colorectal cancer.Colorectal Dis. (2009) (Epub ahead of print).

10.1038/bjc.1983.198

10.1111/j.1365-3083.1984.tb00919.x

10.1016/S0002-9610(99)80296-7

Tartter PI : Pretreatment prognostic factors in colorectal cancer patients with synchronous liver metastases.Eur. J. Surg. Oncol.13(6), 485–491 (1987).

10.1245/s10434-008-0267-6

10.1038/sj.bjc.6603558

10.1007/s11605-007-0140-0

10.1097/SLA.0b013e318142d964

10.1016/j.ejso.2007.02.014

10.1002/jso.21103

10.1002/jso.21294

10.1016/j.ejca.2008.08.019

10.1002/cncr.20976

10.3748/wjg.v12.i34.5495

10.1111/j.1478-3231.2007.01550.x

10.1007/s00268-008-9552-6

10.1002/jso.21001

10.1016/S0002-9610(01)00684-5

10.1007/BF02573067

10.1002/jso.10275

10.1097/01.sla.0000080822.22415.cb

10.1016/j.jamcollsurg.2004.01.022

10.1111/j.1442-2050.2005.00474.x

10.3748/wjg.v12.i23.3746

10.1038/sj.bjc.6603150

10.1016/j.surg.2008.08.015

10.1016/j.radonc.2009.01.002

10.1159/000012186

10.1053/ejso.2002.1405

10.1159/000094562

10.1016/j.ejso.2008.12.002

Schwarz RE , KenyH: Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma.Hepatogastroenterology48(41), 1493–1498 (2001).

Suzuki K , AiuraK, KitagouMet al.: Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients.Hepatogastroenterology51(57), 847–853 (2004).

10.1038/sj.bjc.6602305

10.1055/s-0037-1613413

10.1177/014860710302700110

10.1038/sj.bjc.6603682

10.1200/JCO.2008.18.9068

Menczer J , SchejterE, GevaD, GinathS, ZakutH: Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival.Eur. J. Gynaecol. Oncol.19(1), 82–84 (1998).

10.1016/S0301-2115(98)00227-9

10.1007/s00262-008-0516-3

10.1097/01.AOG.0000102703.21556.0B

10.1016/j.ygyno.2003.09.002

10.1593/neo.06619

10.1158/1078-0432.CCR-07-1044

10.1007/s00404-008-0673-9

10.1016/S0002-9378(94)70225-X

10.1159/000113051

10.1016/j.ejca.2007.11.011

10.1159/000093905

10.1002/cncr.23461

10.1159/000112601

10.1038/sj.bjc.6602406

10.1111/j.1464-410X.2007.07408.x

10.1111/j.1442-2042.1998.tb00380.x

10.1016/S0022-5347(05)64453-9

10.1097/00008469-200206000-00008

10.1111/j.1442-2042.2004.00808.x

10.1016/j.urology.2003.10.039

10.1111/j.1442-2042.2006.01563.x

10.1016/S0022-5347(05)00526-4

10.1111/j.1464-410X.2006.06437.x

10.1038/sj.bjc.6603034

10.1002/cncr.22896

10.1111/j.1464-410X.2006.06497.x

10.1111/j.1464-410X.2007.06934.x

10.1159/000106322

10.1111/j.1464-410X.2007.07363.x

10.1016/j.juro.2008.10.156

10.1002/cncr.22400

10.1093/carcin/bgp127

Cancerstats (2004) www.cancerresearchuk.org.